{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T20:51:00Z","timestamp":1784839860081,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81102397"],"award-info":[{"award-number":["81102397"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK2012761"],"award-info":[{"award-number":["BK2012761"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Qing Lan Project of Jiangsu Province","award":["02432009"],"award-info":[{"award-number":["02432009"]}]},{"name":"Innovative Project for Graduate Cultivation of Jiangsu Province","award":["CXZZ11-0807"],"award-info":[{"award-number":["CXZZ11-0807"]}]},{"name":"Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University","award":["JKGQ201107"],"award-info":[{"award-number":["JKGQ201107"]}]},{"name":"Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University","award":["JKPZ2013004"],"award-info":[{"award-number":["JKPZ2013004"]}]},{"name":"Key New Drug Innovation Project from the Ministry of Science and Technology of China","award":["2009ZX09310004"],"award-info":[{"award-number":["2009ZX09310004"]}]},{"name":"Fostering Plan of University Scientific & Technological Innovation Team of Jiangsu Qing Lan Project (2014)"},{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"crossref","award":["2009CB903300"],"award-info":[{"award-number":["2009CB903300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.ejps.2015.12.019","type":"journal-article","created":{"date-parts":[[2015,12,18]],"date-time":"2015-12-18T01:42:41Z","timestamp":1450402961000},"page":"79-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Biological evaluation of PEG modified nanosuspensions based on human serum albumin for tumor targeted delivery of paclitaxel"],"prefix":"10.1016","volume":"83","author":[{"given":"Tingjie","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meirong","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2015.12.019_bb0005","doi-asserted-by":"crossref","first-page":"7939","DOI":"10.1038\/ncomms8939","article-title":"A paclitaxel-loaded recombinant polypeptide nanoparticle outperforms Abraxane in multiple murine cancer models","volume":"6","author":"Bhattacharyya","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejps.2015.12.019_bb0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.addr.2012.09.006","article-title":"Nanoparticles in cancer therapy and diagnosis","volume":"64","author":"Brigger","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2015.12.019_bb0015","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.fct.2014.03.013","article-title":"Systemic toxicity induced by paclitaxel in vivo is associated with the solvent cremophor EL through oxidative stress-driven mechanisms","volume":"68","author":"Campos","year":"2014","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejps.2015.12.019_bb0020","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/jcph.304","article-title":"Pharmacokinetics and pharmacodynamics of nab-paclitaxel in patients with solid tumors: disposition kinetics and pharmacology distinct from solvent-based paclitaxel","volume":"54","author":"Chen","year":"2014","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2015.12.019_bb0025","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jconrel.2010.08.027","article-title":"To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery","volume":"148","author":"Danhier","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2015.12.019_bb0030","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jconrel.2011.09.069","article-title":"Impact of albumin on drug delivery\u2014new applications on the horizon","volume":"157","author":"Elsadek","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2015.12.019_bb0035","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2011.07.031","article-title":"Albumin-based nanoparticles as potential controlled release drug delivery systems","volume":"157","author":"Elzoghby","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2015.12.019_bb0040","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.ejca.2015.05.004","article-title":"Reprint of: cancer incidence and mortality patterns in europe: estimates for 40 countries in 2012","volume":"51","author":"Ferlay","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejps.2015.12.019_bb0045","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s00520-014-2487-6","article-title":"Substantial decreases in the number and diversity of microbiota during chemotherapy-induced gastrointestinal mucositis in a rat model","volume":"23","author":"Fijlstra","year":"2015","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.ejps.2015.12.019_bb0050","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.clbc.2014.02.001","article-title":"Nab-paclitaxel for the treatment of aggressive metastatic breast cancer","volume":"14","author":"Gluck","year":"2014","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.ejps.2015.12.019_bb0055","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10555-010-9235-2","article-title":"Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals","volume":"29","author":"Gupta","year":"2010","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.ejps.2015.12.019_bb0060","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1021\/am5082793","article-title":"Hybrid lipid-capped mesoporous silica for stimuli-responsive drug release and overcoming multidrug resistance","volume":"7","author":"Han","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejps.2015.12.019_bb0065","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.carbpol.2013.01.008","article-title":"Organized polysaccharide fibers as stable drug carriers","volume":"94","author":"Janaswamy","year":"2013","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejps.2015.12.019_bb0070","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.tifs.2014.08.006","article-title":"Nanotechnology for increased micronutrient bioavailability","volume":"40","author":"Joye","year":"2014","journal-title":"Trends Food Sci. Technol."},{"key":"10.1016\/j.ejps.2015.12.019_bb0075","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijpharm.2010.10.041","article-title":"Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity","volume":"403","author":"Kim","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2015.12.019_bb0080","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0021-9797(87)90009-9","article-title":"Interaction of poly(L-lactide) microcapsule surface with plasma proteins:reversal of zeta potential caused by fibrinogen","volume":"115","author":"Kimiko","year":"1987","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ejps.2015.12.019_bb0085","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.npep.2014.02.001","article-title":"Peptidergic intraepidermal nerve fibers in the skin contribute to the neuropathic pain in paclitaxel-induced peripheral neuropathy","volume":"48","author":"Ko","year":"2014","journal-title":"Neuropeptides"},{"key":"10.1016\/j.ejps.2015.12.019_bb0090","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.clon.2014.10.001","article-title":"Dose-dense paclitaxel in advanced ovarian cancer","volume":"27","author":"Kumar","year":"2015","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.ejps.2015.12.019_bb0095","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijpharm.2014.04.010","article-title":"Direct comparison of two albumin-based paclitaxel-loaded nanoparticle formulations: is the crosslinked version more advantageous?","volume":"468","author":"Li","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2015.12.019_bb0100","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ijpharm.2015.05.070","article-title":"Preparation and characterization of paclitaxel nanosuspension using novel emulsification method by combining high speed homogenizer and high pressure homogenization","volume":"490","author":"Li","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2015.12.019_bb0105","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.4049\/jimmunol.1203539","article-title":"Profound impairment of adaptive immune responses by alkylating chemotherapy","volume":"190","author":"Litterman","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejps.2015.12.019_bb0110","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.phymed.2015.03.011","article-title":"Pharmacokinetic synergy from the taxane extract of taxus chinensis improves the bioavailability of paclitaxel","volume":"22","author":"Liu","year":"2015","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejps.2015.12.019_bb0115","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ijpharm.2014.05.032","article-title":"Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo","volume":"471","author":"Lu","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2015.12.019_bb0120","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.addr.2011.02.002","article-title":"Prodrugs for improving tumor targetability and efficiency","volume":"63","author":"Mahato","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2015.12.019_bb0125","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ijpharm.2015.08.055","article-title":"Facile one-pot formulation of TRAIL-embedded paclitaxel-bound albumin nanoparticles for the treatment of pancreatic cancer","volume":"494","author":"Min","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2015.12.019_bb0130","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jconrel.2015.09.060","article-title":"Multifunctional theranostic contrast agent for photoacoustics- and ultrasound-based tumor diagnosis and ultrasound-stimulated local tumor therapy","volume":"218","author":"Moon","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2015.12.019_bb0135","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.biomaterials.2015.02.012","article-title":"A paper-based invasion assay: assessing chemotaxis of cancer cells in gradients of oxygen","volume":"52","author":"Mosadegh","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2015.12.019_bb0140","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.cell.2012.07.023","article-title":"Cancer vulnerabilities unveiled by genomic loss","volume":"150","author":"Nijhawan","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejps.2015.12.019_bb0145","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.bbamem.2012.10.013","article-title":"FTIR, (1)H NMR and EPR spectroscopy studies on the interaction of flavone apigenin with dipalmitoylphosphatidylcholine liposomes","volume":"1828","author":"Pawlikowska-Pawlega","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejps.2015.12.019_bb0150","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejpb.2015.03.018","article-title":"Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy","volume":"93","author":"Perez-Herrero","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2015.12.019_bb0155","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2174\/156800909787580944","article-title":"Lipoamino acid prodrugs of paclitaxel: synthesis and cytotoxicity evaluation on human anaplastic thyroid carcinoma cells","volume":"9","author":"Pignatello","year":"2009","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.ejps.2015.12.019_bb0160","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ejpb.2010.12.024","article-title":"Internal benchmarking of a human blood\u2013brain barrier cell model for screening of nanoparticle uptake and transcytosis","volume":"77","author":"Ragnaill","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2015.12.019_bb0165","doi-asserted-by":"crossref","first-page":"7106","DOI":"10.1016\/j.biomaterials.2010.05.067","article-title":"Paclitaxel-clusters coated with hyaluronan as selective tumor-targeted nanovectors","volume":"31","author":"Rivkin","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2015.12.019_bb0170","doi-asserted-by":"crossref","first-page":"20530","DOI":"10.1021\/acsami.5b06043","article-title":"Preparation of a thermosensitive gel composed of a mPEG-PLGA-PLL-cRGD nanodrug delivery system for pancreatic tumor therapy","volume":"7","author":"Shen","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejps.2015.12.019_bb0175","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.clon.2010.03.014","article-title":"Cytotoxic chemotherapy for differentiated thyroid carcinoma","volume":"22","author":"Sherman","year":"2010","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.ejps.2015.12.019_bb0180","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00280-014-2590-x","article-title":"The safety and efficacy of paclitaxel and carboplatin with or without bevacizumab for treating patients with advanced nonsquamous non-small cell lung cancer with interstitial lung disease","volume":"74","author":"Shimizu","year":"2014","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejps.2015.12.019_bb0185","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.colsurfb.2014.07.025","article-title":"Surface modification of HSA containing magnetic PLGA nanoparticles by poloxamer to decrease plasma protein adsorption","volume":"122","author":"Shubhra","year":"2014","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ejps.2015.12.019_bb0190","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jconrel.2013.09.026","article-title":"Mind the gap: a survey of how cancer drug carriers are susceptible to the gap between research and practice","volume":"172","author":"Stirland","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2015.12.019_bb0195","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jconrel.2013.05.041","article-title":"Nab-paclitaxel mechanisms of action and delivery","volume":"170","author":"Yardley","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2015.12.019_bb0200","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.fct.2013.12.041","article-title":"Toxicological assessment of combined lead and cadmium: acute and sub-chronic toxicity study in rats","volume":"65","author":"Yuan","year":"2014","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejps.2015.12.019_bb0205","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/adfm.201301309","article-title":"Steric protected and illumination-activated tumor targeting accessory for endowing drug-delivery systems with tumor selectivity","volume":"24","author":"Yuan","year":"2014","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.ejps.2015.12.019_bb0210","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3109\/02652048.2011.590614","article-title":"Preparation of the albumin nanoparticle system loaded with both paclitaxel and sorafenib and its evaluation in vitro and in vivo","volume":"28","author":"Zhang","year":"2011","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ejps.2015.12.019_bb0215","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1007\/s11095-014-1320-8","article-title":"Targeted paclitaxel delivery to tumors using cleavable PEG-conjugated solid lipid nanoparticles","volume":"31","author":"Zheng","year":"2014","journal-title":"Pharm. Res."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098715300932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098715300932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T06:41:14Z","timestamp":1589611274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098715300932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":43,"alternative-id":["S0928098715300932"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2015.12.019","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biological evaluation of PEG modified nanosuspensions based on human serum albumin for tumor targeted delivery of paclitaxel","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2015.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}